BACKGROUND: The study aim was to determine the accuracy of axillary ultrasound (AUS) and fine-needle aspiration biopsy (FNAB)/needle core biopsy in axillary breast cancer staging. METHODS: We reviewed 256 patients with clinically node-negative breast cancer who underwent AUS +/- FNAB/needle core biopsy. AUS-guided FNAB/needle core biopsy was compared with histopathology to determine sensitivity, specificity, negative predictive value, and positive predictive value. RESULTS: AUS-guided FNAB/needle core biopsy and final pathology were positive in 72 of 256 patients (28%). In 125 of 256 cases (49%), the AUS and final pathology were negative. Two of 110 patients had a false-positive FNAB (1.8%); both received neoadjuvant chemotherapy. Nine patients (8%) had a false-negative FNAB/needle core biopsy; the median size of lymph node metastasis was 3 mm. The sensitivity and specificity of AUS-guided FNAB/needle core biopsy was 71% and 99%, respectively, with a negative predictive value of 84% and a positive predictive value of 97%. CONCLUSIONS: AUS-guided FNAB/needle core biopsy is accurate in predicting the status of the axilla in 70% of clinically node-negative breast cancer patients. This technique is minimally invasive with a low complication rate and can obviate the need for staged lymph node procedures.
BACKGROUND: The study aim was to determine the accuracy of axillary ultrasound (AUS) and fine-needle aspiration biopsy (FNAB)/needle core biopsy in axillary breast cancer staging. METHODS: We reviewed 256 patients with clinically node-negative breast cancer who underwent AUS +/- FNAB/needle core biopsy. AUS-guided FNAB/needle core biopsy was compared with histopathology to determine sensitivity, specificity, negative predictive value, and positive predictive value. RESULTS: AUS-guided FNAB/needle core biopsy and final pathology were positive in 72 of 256 patients (28%). In 125 of 256 cases (49%), the AUS and final pathology were negative. Two of 110 patients had a false-positive FNAB (1.8%); both received neoadjuvant chemotherapy. Nine patients (8%) had a false-negative FNAB/needle core biopsy; the median size of lymph node metastasis was 3 mm. The sensitivity and specificity of AUS-guided FNAB/needle core biopsy was 71% and 99%, respectively, with a negative predictive value of 84% and a positive predictive value of 97%. CONCLUSIONS: AUS-guided FNAB/needle core biopsy is accurate in predicting the status of the axilla in 70% of clinically node-negative breast cancerpatients. This technique is minimally invasive with a low complication rate and can obviate the need for staged lymph node procedures.
Authors: J Feu; F Tresserra; R Fábregas; B Navarro; P J Grases; J C Suris; A Fernández-Cíd; X Alegret Journal: Radiology Date: 1997-12 Impact factor: 11.105
Authors: J Bonnema; A N van Geel; B van Ooijen; S P Mali; S L Tjiam; S C Henzen-Logmans; P I Schmitz; T Wiggers Journal: World J Surg Date: 1997 Mar-Apr Impact factor: 3.352
Authors: H M Kuerer; A A Sahin; K K Hunt; L A Newman; T M Breslin; F C Ames; M I Ross; A U Buzdar; G N Hortobagyi; S E Singletary Journal: Ann Surg Date: 1999-07 Impact factor: 12.969
Authors: Isabelle Bedrosian; Deepak Bedi; Henry M Kuerer; Bruno D Fornage; Lori Harker; Merrick I Ross; Frederick C Ames; Savitri Krishnamurthy; Beth S Edeiken-Monroe; Funda Meric; Barry W Feig; Jeri Akins; S Eva Singletary; Nadeem Q Mirza; Kelly K Hunt Journal: Ann Surg Oncol Date: 2003-11 Impact factor: 5.344
Authors: E E Deurloo; P J Tanis; K G A Gilhuijs; S H Muller; R Kröger; J L Peterse; E J Th Rutgers; R Valdés Olmos; L J Schultze Kool Journal: Eur J Cancer Date: 2003-05 Impact factor: 9.162
Authors: D Krag; D Weaver; T Ashikaga; F Moffat; V S Klimberg; C Shriver; S Feldman; R Kusminsky; M Gadd; J Kuhn; S Harlow; P Beitsch Journal: N Engl J Med Date: 1998-10-01 Impact factor: 91.245
Authors: V Kuenen-Boumeester; M Menke-Pluymers; A Y de Kanter; I-M A Obdeijn; D Urich; T H Van Der Kwast Journal: Eur J Cancer Date: 2003-01 Impact factor: 9.162
Authors: Todd N Erpelding; Chulhong Kim; Manojit Pramanik; Ladislav Jankovic; Konstantin Maslov; Zijian Guo; Julie A Margenthaler; Michael D Pashley; Lihong V Wang Journal: Radiology Date: 2010-07 Impact factor: 11.105
Authors: Natalia S Tucker; Amy E Cyr; Foluso O Ademuyiwa; Adel Tabchy; Krystl George; Piyush K Sharma; Linda X Jin; Souzan Sanati; Rebecca Aft; Feng Gao; Julie A Margenthaler; William E Gillanders Journal: Ann Surg Date: 2016-12 Impact factor: 12.969